Highmark Marketing Inc.
CNSX : HMK
FRANKFURT : 1HM
OTC PINK : HMKTF

Highmark Marketing Inc.

December 30, 2014 19:15 ET

Highmark Marketing Inc. Closes First Tranche of Non-Brokered Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 30, 2014) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Highmark Marketing Inc. ("Highmark") (CSE:HMK)(FRANKFURT:1HM)(OTC PINK:HMKTF) is pleased to announce that it has completed the first tranche of a non-brokered private placement by issuing 589,000 units at a price of $0.085 per unit for gross proceeds of $50,065. The private placement, which was announced on October 16, 2014 and revised on November 26, 2014, has a total offering of up to 4 million units. Each unit consists of one common share and one full share purchase warrant. Each warrant is exercisable into one common share for a period of 36 months from the date of issuance at a price of $0.15 per share. The common share and full share purchase warrant are each subject to a hold period expiring on May 1, 2015.

Highmark also announces that it has paid an aggregate finder's fee of $5,006.50, representing 10 per cent of the gross proceeds received from subscribers introduced by the finders to Highmark. In addition, Highmark has issued an aggregate of 58,900 warrants to finders, representing 10 per cent of the number of units sold to subscribers introduced by the finders to Highmark. Each warrant entitles the finders to purchase one share of Highmark at an exercise price of $0.15 for a period of 36 months from the date of issuance. The warrants will also be subject to a hold period of four months and one day from the date of issuance, ending on May 1, 2015. Net proceeds of the first tranche of the private placement will be used for working capital.

About Highmark

Highmark is a nutraceutical company, based in British Columbia, focused on bringing the health benefits of natural and herbal remedies to the market. Highmark intends to acquire, license, distribute, and market products in the nutraceutical industry.

Further information about Highmark is available under its profile on the SEDAR website www.sedar.com and on Highmark's page on the CSE website.

The CSE has not reviewed, nor approved or disapproved the content of this press release.

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of Highmark. Forward-looking information is based on certain key expectations and assumptions made by the management of Highmark, including future plans for acquisitions. Although Highmark believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Highmark can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. Highmark disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.

Contact Information